| Financial Year |
March 31 2023 |
| Monetary Funds |
975,930,300.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,123,976,139.68 |
| Advances to Suppliers |
395,774,887.85 |
| Other Receivables |
134,703,022.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,049,444,933.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
168,005,318.74 |
| Total Current Assets |
5,896,766,292.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,760,853,203.85 |
| Investment Properties |
179,823,355.54 |
| Fixed Assetes |
4,493,547,459.28 |
| Under-construction Projects |
918,688,802.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,182,881,866.37 |
| R&D expenses |
5,352,431.88 |
| Goodwill |
47,584,152.97 |
| Long-Term Deferred and Prepaid Expenses |
315,003,615.78 |
| Deferred Income Tax Assets |
366,379,022.62 |
| Other Non-Current Assets |
287,926,340.63 |
| Sub-Total of Non-Current Assets |
11,438,795,703.55 |
| Total Assets |
17,335,561,996.32 |
| Short-Term Loans |
3,781,398,205.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
832,397,690.36 |
| Accounts Received In Advance |
19,334,142.81 |
| Employee Compensation Payable |
372,638,604.70 |
| Taxes Payable |
166,139,439.39 |
| Interest Payable |
-- |
| Dividend Payable |
31,151,173.80 |
| Other payables |
274,530,535.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
337,117,320.74 |
| Other Current Liabilities |
64,782,683.31 |
| Sub-Total of Current Liabilities |
6,304,375,997.82 |
| Long-term Loans |
1,353,465,996.28 |
| Bonds Payable |
498,612,421.96 |
| Long-Term Accounts Payable |
351,200,255.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,824,872.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,946,666,768.36 |
| Total Liabilities |
9,251,042,766.18 |
| Paid-In Capital(Or Share Stock) |
723,840,000.00 |
| Capital Surplus |
1,755,928,104.00 |
| Surplus Reserve |
206,932,908.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,350,953,814.51 |
| Minority Stockholder's Interest |
2,071,183,707.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,013,335,522.30 |
| Owner's Equity（Stockholder's Equity） |
8,084,519,230.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,335,561,996.32 |
